|
Schlusskurs
Shanghai S.E.
20.04.2026
|
% 5 Tage
|
Veränd. 1. Jan.
|
|
24,82 CNY
|
-0,32 %
|
 |
+1,97 %
|
-5,63 %
|
|
01.04. |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 24, 2025.
| | |
27.02. |
Hubei Jumpcan Secures Exclusive China Rights For Eczema Treatment
| | |
03.02. |
Akeso Grants Commercialization Rights for Hypercholesterolemia Drug to Hubei Jumpcan Pharmaceutical Unit
| | |
03.02. |
Jumpcan Pharmaceutical Gets Rights for Pumeixitinib Nasal Spray for 100 Million Yuan
| | |
04.01. |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 24, 2025.
| | |
24.11. |
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
| | |
24.11. |
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
| | |
28.10.25 |
Jumpcan Pharmaceutical's Q3 Profit Drops 47%, Revenue Falls 33%
| | |
27.10.25 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
17.09.25 |
Jumpcan Pharma Gets Registration Certificate for Lidocaine Cataplasms
| | |
25.08.25 |
Hubei Jumpcan Pharmaceutical's Attributable Profit Slides 46% in H1; Shares Fall 4%
| | |
22.08.25 |
Hubei Jumpcan Pharmaceutical H1 net profit down 45.9% Y/Y
| | |
22.08.25 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
21.07.25 |
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 23, 2024.
| | |
21.07.25 |
Cao Fei Completes Partial Tender Offer for Jumpcan Pharmaceutical Shares
| | |
21.07.25 |
Jumpcan Pharmaceutical Gets Registration Certificate for Masiloxavir Tablets
| | |
21.07.25 |
Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 22, 2024, has closed with 914,200 shares, representing 0.1% for CNY 25.01 million.
| | |
20.07.25 |
Hubei Jumpcan Pharma's trading to resume
| | |
17.07.25 |
Hubei Jumpcan Pharma's share trade to halt
| | |
17.07.25 |
Cao Fei completed the acquisition of 0.0018% stake in Hubei Jumpcan Pharmaceutical Co., Ltd. for CNY 0.41 million.
| | |
08.07.25 |
Jumpcan Gets Approval for Traditional Chinese Drug for Constipation, Stomach Strengthening
| | |
16.06.25 |
Jumpcan Pharmaceutical Receives Tender Offer Worth 9.45 Billion Yuan
| | |
16.06.25 |
Cao Fei made an offer to acquire 38.2% stake in Hubei Jumpcan Pharmaceutical Co., Ltd. for CNY 8.7 billion.
| | |
28.04.25 |
Hubei Jumpcan Pharmaceutical Co., Ltd. announces Annual dividend, payable on June 30, 2025
| | |
25.04.25 |
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| |
Keine Ergebnisse zu dieser Suche Bitte wählen Sie Ihre Ausgabe Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
| 
